(Q39884202)

15 September 2017

title

Involvement of hepatoma-derived growth factor in the growth inhibition of hepatocellular carcinoma cells by vitamin K(2). (English)

1 reference

15 September 2017

0 references

1 reference

Teruhisa Yamamoto

1

1 reference

15 September 2017

Hideji Nakamura

2

1 reference

15 September 2017

Weidong Liu

3

1 reference

15 September 2017

Ke Cao

4

1 reference

15 September 2017

Shohei Yoshikawa

5

1 reference

15 September 2017

Hirayuki Enomoto

6

1 reference

15 September 2017

Yoshinori Iwata

7

1 reference

15 September 2017

Noritoshi Koh

8

1 reference

15 September 2017

Masaki Saito

9

1 reference

15 September 2017

Hiroyasu Imanishi

10

1 reference

15 September 2017

Soji Shimomura

11

1 reference

15 September 2017

Hiroko Iijima

12

1 reference

15 September 2017

Toshikazu Hada

13

1 reference

15 September 2017

Shuhei Nishiguchi

14

1 reference

15 September 2017

publication date

13 February 2009

1 reference

Journal of Gastroenterology

15 September 2017

published in

1 reference

15 September 2017

volume

44

1 reference

15 September 2017

issue

3

1 reference

15 September 2017

page(s)

228-235

1 reference

Hepatoma-derived growth factor is highly expressed in developing liver and promotes fetal hepatocyte proliferation.

15 September 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00535-008-2304-4

Hepatoma-derived growth factor is a novel prognostic factor for hepatocellular carcinoma

21 January 2018

1 reference

12 December 2020

Vitamin K2 inhibits the growth and invasiveness of hepatocellular carcinoma cells via protein kinase A activation

1 reference

12 December 2020

Hepatoma-derived growth factor stimulates cell growth after translocation to the nucleus by nuclear localization signals

1 reference

12 December 2020

Role of vitamin K2 in the development of hepatocellular carcinoma in women with viral cirrhosis of the liver

1 reference

12 December 2020

Hepatoma-derived growth factor stimulates smooth muscle cell growth and is expressed in vascular development

1 reference

12 December 2020

Vitamin K2 inhibits the proliferation of HepG2 cells by up-regulating the transcription of p21 gene

1 reference

12 December 2020

Expression of hepatoma-derived growth factor is correlated with lymph node metastasis and prognosis of gastric carcinoma.

1 reference

12 December 2020

Expression of hepatoma-derived growth factor is a strong prognostic predictor for patients with early-stage non-small-cell lung cancer

1 reference

12 December 2020

Nuclear targeting is required for hepatoma-derived growth factor-stimulated mitogenesis in vascular smooth muscle cells

1 reference

12 December 2020

Menatetrenone, a vitamin K2 analogue, inhibits hepatocellular carcinoma cell growth by suppressing cyclin D1 expression through inhibition of nuclear factor kappaB activation

1 reference

12 December 2020

The growth inhibitory effects of vitamins K and their actions on gene expression

1 reference

12 December 2020

Hepatoma-derived growth factor induces tumorigenesis in vivo through both direct angiogenic activity and induction of vascular endothelial growth factor

1 reference

12 December 2020

The effect of menatetrenone, a vitamin K2 analog, on disease recurrence and survival in patients with hepatocellular carcinoma after curative treatment: a pilot study

1 reference

12 December 2020

Diverse cellular transformation capability of overexpressed genes in human hepatocellular carcinoma

1 reference

12 December 2020

Hepatoma-derived growth factor is a novel prognostic factor for patients with pancreatic cancer.

1 reference

12 December 2020

An endothelial growth factor involved in rat renal development

1 reference

12 December 2020

Acyclic retinoid inhibits human hepatoma cell growth by suppressing fibroblast growth factor-mediated signaling pathways.

1 reference

12 December 2020

Down-regulation of hepatoma-derived growth factor inhibits anchorage-independent growth and invasion of non-small cell lung cancer cells

1 reference

12 December 2020

Expression of hepatoma‐derived growth factor in hepatocellular carcinoma

1 reference

12 December 2020

Molecular cloning of complementary DNA for a novel human hepatoma-derived growth factor. Its homology with high mobility group-1 protein

1 reference

12 December 2020

Antisense oligonucleotides of hepatoma-derived growth factor (HDGF) suppress the proliferation of hepatoma cells

1 reference

12 December 2020

Differential effects of two growth inhibitory K vitamin analogs on cell cycle regulating proteins in human hepatoma cells.

1 reference

12 December 2020

Expression of hepatoma-derived growth factor in hepatocarcinogenesis

1 reference

12 December 2020

Hepatoma-derived growth factor is a pulmonary endothelial cell-expressed angiogenic factor

1 reference

12 December 2020

In vitro and in vivo antitumor effects of vitamin K5 on hepatocellular carcinoma

1 reference

12 December 2020

Expression level of hepatoma-derived growth factor correlates with tumor recurrence of esophageal carcinoma

1 reference

12 December 2020

Antitumor effects of vitamins K1, K2 and K3 on hepatocellular carcinoma in vitro and in vivo

1 reference

12 December 2020

Hepatoma-derived growth factor as a prognostic marker in completely resected non-small-cell lung cancer

1 reference

12 December 2020

Vitamin K in the treatment of cancer

1 reference

12 December 2020

Synergistic growth inhibition by acyclic retinoid and vitamin K2 in human hepatocellular carcinoma cells

1 reference

12 December 2020

Partial purification and characterization of human hepatoma-derived growth factor

1 reference

12 December 2020

10.1007/S00535-008-2304-4

Identifiers

DOI

1 reference

15 September 2017

1 reference